$$Question: An angel investor is considering funding one of 5 early-stage tech startups, each focusing on a unique field: AI, biotech, clean energy, quantum computing, and blockchain. If the investor randomly selects 3 startups to fund, what is the probability that both the AI and biotech startups are among the selected ones? - Redraw
$$Question: An angel investor is considering funding one of 5 early-stage tech startups, each focusing on a unique field—AI, biotech, clean energy, quantum computing, and blockchain. If the investor randomly selects 3 startups to fund, what is the probability that both the AI and biotech startups are among the selected ones?
$$Question: An angel investor is considering funding one of 5 early-stage tech startups, each focusing on a unique field—AI, biotech, clean energy, quantum computing, and blockchain. If the investor randomly selects 3 startups to fund, what is the probability that both the AI and biotech startups are among the selected ones?
As venture capital shifts toward high-potential tech innovation, early-stage investors increasingly face complex portfolio choices. Recent trends show growing interest in breakthrough technologies that shape industries—from intelligent systems and medical breakthroughs to sustainable infrastructure and secure digital economies. With limited capital and rising competition, decisions are driven by careful risk assessment and strategic vision. This probabilistic question explores how likely it is that two key scientific frontiers—AI and biotech—would be included in a randomly selected three-company slate.
Understanding the Context
Why This Question Matters Now
In today’s innovation landscape, AI and biotech represent two of the most transformative and high-stakes growth areas. Neither field alone dominates investment flows, but together they signal core future momentum in technology and healthcare. Investors increasingly ask: how does portfolio balance affect impact and return? Understanding selection probabilities helps clarify strategic focus and informs due diligence depth—especially for angel investors evaluating ecosystem-level alignment.
How to Calculate the Probability: A Practical Breakdown
Image Gallery
Key Insights
We’re selecting 3 startups out of 5, and want the chance both AI and biotech are selected. First, the total number of ways to choose 3 from 5 is 10. Second, if both AI and biotech must be funded, the third startup must come from the remaining 3 firms. That gives 3 favorable combinations. So the probability is 3 out of 10—30%. This might seem simple, but the real value lies in how probabilistic reasoning illuminates decision-making under uncertainty.
Common Questions About Startup Selection
Why do startups exclude AI and biotech most often?
Many early-stage companies focus on narrower niches or rapid pilot validation to de-risk investor exposure. Biotech, in particular, faces long development timelines and high regulatory hurdles—factors that influence funding timing and quantity.
Can investors consistently pick both AI and biotech?
Given limited selection, randomness and intentional strategy heavily shape outcomes. While possible, it’s not guaranteed—especially when resources are fragmented and pitch timelines overlap.
🔗 Related Articles You Might Like:
📰 Final Alert: These 12 Anniversary Gifts Are Perfect for Your 12th Edition! 📰 Don’t Miss These 12 Anniversary Gift Ideas to Celebrate Your Love! 📰 12 Timeless Anniversary Gifts Built to Make Your 12th Year Unforgettable! 📰 Cleb 4660285 📰 Calories For Fuji Apple 7353160 📰 Master Retention Like A Pro 5 Game Changing Strategies Every Business Needs 4293797 📰 The Perimeter Is Given By 2W 2W 240 3694117 📰 From Blood To Blades Explore The Legend Of Souls And Swords Like Never Before 7005527 📰 She Wore This Dress And Landed The Best Jobwhat Was It 7108762 📰 5X This Search Oig Exclusion List Is Hacking Data Integritysee Whats Blacklisted Today 6537896 📰 Kevin James Movies 4071740 📰 Discover The Secret To Authentic Spanish Food Pinchosthe Way Locals Eat Them 9396034 📰 Gazprom Stock 1542180 📰 Apartments For Rent Without Credit Check 9375266 📰 Neighborhood Parking 7249197 📰 Why Traders Are Rushing Amlx The Stock With Unstoppable Momentum In 2024 3484837 📰 Youll Never Guess How Fidelitys Back Door Roth Step By Step Boosts Your Savings Try It Today 7437364 📰 I Didnt Expect My Study Life To Fall This Hardheres What I Learned 4853134Final Thoughts
Real Opportunities and Practical Considerations
Pros of funding both sectors together:
Balancing AI’s scaling potential with biotech’s long-term impact creates resilient portfolios. Diverse bets reduce overreliance on one technological wave.
Cons and risks:
AI projects may dominate short-term returns, whereas biotech often demands patience. Cash flow expectations differ widely—blending them can strain timing.
